Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” - sprookjes - yvandenbroek - TriplyDB

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

http://www.wikidata.org/entity/Q22252938

about

Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS)High nationwide incidence of multiple sclerosis in Sweden Proteomic profiling in multiple sclerosis clinical courses reveals potential biomarkers of neurodegeneration Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis Association of retinal and macular damage with brain atrophy in multiple sclerosis Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis Chapter 11: Genome-wide association studies Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis Sensitivity to heat in MS patients: a factor strongly influencing symptomology--an explorative survey Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis New and emerging disease modifying therapies for multiple sclerosis Multiple Sclerosis: Where Will We Be in 2020?Treatment with disease modifying drugs for people with a first clinical attack suggestive of multiple sclerosis Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis Fingolimod for relapsing-remitting multiple sclerosis Memory rehabilitation for people with multiple sclerosis Teriflunomide for multiple sclerosis Dimethyl fumarate for multiple sclerosis Sodium channel blockers for neuroprotection in multiple sclerosis Telerehabilitation for persons with multiple sclerosis Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis Exercise therapy for fatigue in multiple sclerosis Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis Information provision for people with multiple sclerosis Dimethyl fumarate for multiple sclerosis Carnitine for fatigue in multiple sclerosis Mycophenolate mofetil for relapsing-remitting multiple sclerosis Teriflunomide for multiple sclerosis Laquinimod for multiple sclerosis Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis Neuropsychological rehabilitation for multiple sclerosis Sodium channel blockers for neuroprotection in multiple sclerosis Daclizumab for relapsing remitting multiple sclerosis Mycophenolate mofetil for relapsing-remitting multiple sclerosis

P2860

Q21093270-09E49263-3D43-4543-9F28-C108B4A886E4 Q21131936-44E4DF8E-EBBE-43E3-9DF9-93172022BE30 Q21131975-6EE01AD7-0F34-4E4F-B5A0-D2EE3D644884 Q21135278-CCFC9E21-7B56-4D45-9B6D-8F84789217B2 Q21135504-8143B496-B5F9-463F-94DA-56473AC6C54E Q21144285-DBB625B0-B54C-4A24-B52F-6FBCE5BBF737 Q21145310-D2BCA59C-C803-4CAE-AFD4-584E29283828 Q21203734-A98B4DDA-13F3-4131-BB56-CC72C861471E Q21245912-0CDBB3BA-2652-426B-BB4A-719220E9A8DD Q21261398-A4FD90FD-89A0-440E-88FE-2D1BD61F97C8 Q21261507-913E5302-AD17-4E02-BFB2-C9D282CE3166 Q21559486-5EAAA7E4-8012-4816-BCFA-F843D15A0C6B Q21560827-E317F18E-E96C-4496-8C7B-B0AD9769294C Q21560983-CAF585E7-DC3E-4250-9FA1-BFAAF88A4E14 Q22242024-6A86C342-1AF8-44F4-9098-99518ADEA74F Q22242305-65169649-9D7E-401A-A7DA-68A00D351944 Q22252863-6B82BF3D-49DE-4C2F-BD06-CD11E5586DF5 Q24185806-1E7D3662-D92D-4C7A-911A-3236D62C12D2 Q24185820-E97EF143-9609-4F6A-A724-9129306D4A82 Q24185882-23AFFBF4-9602-4305-859C-855E0A79D784 Q24186011-C756EF1E-D4D2-4192-8F47-42FF908D62C6 Q24186016-E80ABDEB-375C-4732-AA55-3FEB3E19606A Q24186433-A27661F4-67A2-42EB-8843-584CB9DCE98F Q24186448-291F6BB5-780F-4A00-870D-1BF2E04C8F5C Q24186573-52E3421F-2506-4326-9264-7F2E64A25A86 Q24187126-96D27077-14EE-49CC-94FE-35A28EFAAE2E Q24187235-F9B7FEB3-1A77-4724-B49B-AEA35789E4BB Q24188270-7C4B22B6-9CA1-44CB-A78B-39334D48E556 Q24194800-73B1FF42-A4FF-4F2F-9E0B-D03F6E226241 Q24195040-980C8C46-AEF9-40B4-826F-593B87D698A0 Q24197602-61459A18-9E66-4F86-B2F6-139DE0F5DFFC Q24197748-D7BA05A9-1A33-4524-A05F-AF6456709998 Q24197935-240979CA-EDE2-4AC4-92D8-9D3E0E540EA5 Q24198146-B480D60E-0B4E-484C-9EE9-0B9118A53E88 Q24198180-B6F90652-79B9-49C5-91B7-839A352C729E Q24200422-A975B31B-5EF4-43A2-8429-5CC0B16F3B07 Q24200424-1065AC74-B923-4694-B477-D72D1BE7557B Q24200461-7808E1D7-F7BC-4371-AF7A-119456604CEE Q24200496-C10EAE9A-5DAE-4236-8D11-83F8006A438D Q24200517-CC11E994-0C56-4A93-BF04-BE888D16FCD1

P2860

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

http://www.wikidata.org/entity/Q22252938

description

2005 nî lūn-bûn

@nan

2005 թուականին հրատարակուած գիտական յօդուած

@hyw

2005 թվականին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@ast

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@en

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@en-gb

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@nl

type

label

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@ast

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@en

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@en-gb

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@nl

altLabel

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

@en

prefLabel

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@ast

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@en

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@en-gb

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@nl

P1433

Q22252938-EAC7156A-A98B-4EA6-BD22-88E8812D3080

P1476

Q22252938-52B3E996-8C17-4B82-8DCD-302E37DF3E5D

P2093

Q22252938-197FF67C-5D5B-4538-B419-C613512627CA

Q22252938-1B525D56-7C9F-4A62-8D3F-075E07B18405

Q22252938-31A470E8-551D-44BA-9438-542556ECDFE3

Q22252938-4EE95B43-E75C-480C-8F65-1BD601A5190F

Q22252938-5C072275-07EF-4823-9D51-E575485462AA

Q22252938-67F335D2-C9F9-4679-ACC0-47C05A9026B9

Q22252938-AB62BB83-6709-4F44-9DB1-AD918F18C775

Q22252938-D6256E61-12A7-4041-B407-73C2D179C789

Q22252938-D73FD40A-CBCA-402D-8AAF-4EED61624D4C

Q22252938-EDEBE691-CEDA-4A45-A853-43F40CD27D0D

P304

Q22252938-C36F22E1-7FA3-42F4-87E2-6D53D04E4C6C

P31

Q22252938-4A058934-63E2-490C-8403-8B2FFDD41856

P3181

Q22252938-0860DDF5-5717-4B3E-BE46-8EEF76ACBFC3

P356

Q22252938-C75A0C00-5A2F-49F2-B854-520234A60486

P407

Q22252938-E2A765AD-E2FB-4D10-9863-56BD62FBEA93

P433

Q22252938-33BF0704-3AAE-4B58-A7DE-25B34C53D9E3

P478

Q22252938-A0D6041B-0783-4261-AD21-CA62B1A54984

P50

Q22252938-8BB84473-83C3-46FC-AC72-9552A9A982EC

Q22252938-B5C4C238-8EAB-4CDB-9959-1029A805BBFE

Q22252938-E042A492-1B8B-4785-8969-73FBBDF5F8CD

P577

Q22252938-FB2461DE-1BB8-4F7E-97F3-C3CD01D129BF

P5875

Q22252938-61095252-9016-491B-AD6D-1143FB2977B4

P698

Q22252938-0C508C0A-E31B-4D26-AE8C-367317BFC346

P921

Q22252938-02E83566-69ED-4389-8A34-56170B080181

Q22252938-9e2f8c8d-7e8a-4f8d-afcc-92bbacd83533

P3181

P356

P1433

Annals of Neurology

P1476

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

@en

P2093

Alan J. Thompson

http://www.w3.org/2001/XMLSchema#string

Brian G. Weinshenker

http://www.w3.org/2001/XMLSchema#string

Chris H. Polman

http://www.w3.org/2001/XMLSchema#string

Fred D. Lublin

http://www.w3.org/2001/XMLSchema#string

Gilles Edan

http://www.w3.org/2001/XMLSchema#string

Henry F. McFarland

http://www.w3.org/2001/XMLSchema#string

Jerry S. Wolinsky

http://www.w3.org/2001/XMLSchema#string

Luanne M. Metz

http://www.w3.org/2001/XMLSchema#string

Magnhild Sandberg-Wollheim

http://www.w3.org/2001/XMLSchema#string

Paul W. O'Connor

http://www.w3.org/2001/XMLSchema#string

P304

840-846

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

74492

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ANA.20703

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Peter Hartung

Massimo Filippi

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7484025

http://www.w3.org/2001/XMLSchema#string

P698

16283615

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis